On The Line: Canada can build transportation gooder (and sometimes, we did build good)
About this episode
Matt Gurney discusses transportation infrastructure and public policy with expert Reece Martin.
In this episode of On The Line , host Matt Gurney sits down with Reece Martin, transit and transportation expert and new media entrepreneur, for a conversation about infrastructure, public policy, and how an online passion project turned into a career. This episode is brought to you by BioCanRx, a federally-funded Canadian not-for-profit research network focused on cutting-edge cancer immunotherapy research that they’re helping Canadian researchers bring from labs to patients in clinical trials –– all in Canada. A new treatment for your cancer has been approved. Can you get it? Maybe, maybe not. Canada isn’t just one health jurisdiction. At the federal level, Health Canada assesses the safety and efficacy of all drugs and therapies in the country, and in a year — sometimes less — they can approve one for sale in Canada. Once approved, — or sometimes while the assessment is happening— the drug’s cost effectiveness is evaluated by Canada’s Drug Agency. Then the ball goes to the provinces. They work together to negotiate prices with the drug maker, to confirm that it doesn’t duplicate something they’re already stocking, and that its potential value justifies its cost. Only after…
Sponsors
BioCanRx
More episodes of The Line Podcast
- The Line Podcast: Our smoke attack on America has achieved total success
- The Line Podcast: Carney is building a new post-America world
- On The Line: Is Canada finally moving on from the pipeline wars?
- The Line Podcast: Carney gets a pipeline deal. Now let's build the damn thing
- On The Line: On the frontlines of emergency health care in Canada
- The Line Podcast: Carney makes the easy call to fix our most symbolic national disgrace
Explore listener stats, chart rankings, contacts and more on the The Line Podcast podcast page.